Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Food And Drug Administration maintains a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently features 1 pending office action. This single action is assigned to 1 distinct examiner, which represents the current point of interaction with the USPTO.
The work is conducted within 1 distinct art unit, aligning with the requirements of the Biotechnology & Pharmaceuticals field. Jianfeng Song is the busiest examiner for this portfolio and is currently responsible for the 1 pending office action. As there is 1 pending action, this examiner handles the current active correspondence for the company.
Practitioners should note that the outcome of this 1 pending office action is the current focus for the development of the portfolio. The involvement of 1 distinct examiner and 1 distinct art unit means that the prosecution strategy is directed toward a single individual and unit. Success in this 1 pending office action will depend on addressing the specific concerns of Jianfeng Song within the context of the 1 distinct art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SONG, JIANFENG | 1 | 56.3% | +33.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18354345 | COMPOSITIONS AND METHODS FOR FILTERING MICROORGANISMS FROM A FLUID | SONG, JIANFENG | 39d |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18354345 | COMPOSITIONS AND METHODS FOR FILTERING MICROORGANISMS FROM A FLUID | SONG, JIANFENG | 1613 | §103DP | Final Rejection | 39d | Pending | Jul 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial